This episode of Epilepsy Explained focuses on diagnosing epilepsy and features Dr. David E. Burdette, MD, Epilepsy Section Chief at Corewell West Health System.
When it comes to diagnosing epilepsy, it is estimated that over 30% of people with epilepsy also meet the diagnostic criteria for autism. Hear leading theories on the interconnection between autism and epilepsy and why so many children with autism develop epilepsy.
What are the different diagnoses you can receive from genetic testing, and what options are available after your testing results? Also, learn about CURE Epilepsy's Epilepsy Genetics Initiative (EGI).
When looking at diagnosing epilepsy, what are the major barriers to genetic testing in epilepsy? How early is too early for genetic testing in epilepsy? Get the answers to this and more in this webinar.
How have epilepsy patients benefited from advances in EEG technology and what is the role of the EEG and other neuroimaging tools in the future of diagnosing epilepsy and seizure localization?
How difficult has it been for you to get genetic testing approved for your patients with epilepsy? Understand how this impacts the process of diagnosing epilepsy.
Autoimmune epilepsy is important to diagnose because one of the hallmarks of this condition is that it does not generally respond to typical anti-seizure medications. Immunotherapy is often used to treat people with this condition, by reducing inflammation in the brain.
This webinar focuses on the challenges of diagnosing and treating infantile spasms, and how advances in epilepsy medicine and technology have improved this process. This presentation also examines currently available treatment options.
This Treatment Talk will focus on Lennox-Gastaut Syndrome (LGS), a severe form of childhood epilepsy that arises during infancy or early childhood, and the use of the drug fenfluramine to treat patients diagnosed with LGS.